Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Aimmune Therap (AIMT)

34.18 1.97 (6.12%)

02-22 11:34

Open:

34.69

Pre. Close:

32.21

High:

36

Low:

34

Volume:

3,621,431

Market Cap:

1749M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

34.313 - 34.519

34.519 - 34.672

Low:

31.727 - 31.99

31.99 - 32.185

Close:

31.868 - 32.253

32.253 - 32.539

Technical analysis  (as of: 2018-02-22 11:07:27 AM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 44.68     One year: 49.06

Support:

Support1: 32.20    Support2: 26.79

Resistance:

Resistance1: 38.26    Resistance2: 42.00

Pivot:

36.54

Moving Averages:

MA(5): 35.46     MA(20): 36.49

MA(100): 33.98     MA(250): 25.93

MACD:

MACD(12,26): -0.51     Signal(12,26,9): -0.12

%K %D:

%K(14,3): 14.42     %D(3): 29.38

RSI:

RSI(14): 43.10

52-Week:

High: 42  Low: 15.97  Change(%): 76.8

Average Vol(K):

3-Month: 54343  10-Days 121659

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AIMT has closed above bottom band by 23.5%. Bollinger Bands are 26% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 22 Feb 2018 00:22:30 GMT
Aimmune Therapeutics Announces Pricing of Public Offering of Common Stock

Wed, 21 Feb 2018 22:30:07 GMT
Aimmune Therapeutics Inc. (AIMT) Plunges 7.87% on February 21

Tue, 20 Feb 2018 21:22:30 GMT
Investors Are Undervaluing Aimmune Therapeutics Inc (NASDAQ:AIMT) By 48.05 ...

Wed, 14 Feb 2018 12:56:15 GMT
Aimmune Therapeutics Expands Scientific Advisory Board With Appointments of ...

Tue, 20 Feb 2018 22:32:36 GMT
Aimmune Therapeutics Inc. (AIMT) Breaks into New 52-Week High on February 20 ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

51.16

Shares Float (M)

50.38

% Held by Insiders

% Held by Institutions

99.10

Shares Short (K)

2593

Shares Short Prior Month (K)

4460

Stock Financials

EPS

-2.350

EPS Est. Current Year

-2.710

EPS Est. Next Year

-3.260

EPS Est. Next Quarter

-0.820

Forward EPS

-3.079

Book Value (p.s.)

9.040

PEG Ratio

-0.43

Profit Margin

Operating Margin

Return on Assets (ttm)

-55.5

Return on Equity (ttm)

-60.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.269

Qtrly Earnings Growth

Operating Cash Flow (M)

-90.29

Levered Free Cash Flow (M)

-57.40

atoplab.com

Valuation

P/E

-14.77

P/E Growth Ratio

0.08

P/BV

3.84

P/S

P/CF

-19.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.